These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 11779867)

  • 1. Covalent attachment of the SUMO-1 protein to the negative regulatory domain of the c-Myb transcription factor modifies its stability and transactivation capacity.
    Bies J; Markus J; Wolff L
    J Biol Chem; 2002 Mar; 277(11):8999-9009. PubMed ID: 11779867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stress-induced inactivation of the c-Myb transcription factor through conjugation of SUMO-2/3 proteins.
    Sramko M; Markus J; Kabát J; Wolff L; Bies J
    J Biol Chem; 2006 Dec; 281(52):40065-75. PubMed ID: 17077080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A functional SUMO-interacting motif in the transactivation domain of c-Myb regulates its myeloid transforming ability.
    Saether T; Pattabiraman DR; Alm-Kristiansen AH; Vogt-Kielland LT; Gonda TJ; Gabrielsen OS
    Oncogene; 2011 Jan; 30(2):212-22. PubMed ID: 20802522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sterol regulatory element-binding proteins are negatively regulated through SUMO-1 modification independent of the ubiquitin/26 S proteasome pathway.
    Hirano Y; Murata S; Tanaka K; Shimizu M; Sato R
    J Biol Chem; 2003 May; 278(19):16809-19. PubMed ID: 12615929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transactivation properties of c-Myb are critically dependent on two SUMO-1 acceptor sites that are conjugated in a PIASy enhanced manner.
    Dahle Ø; Andersen TØ; Nordgård O; Matre V; Del Sal G; Gabrielsen OS
    Eur J Biochem; 2003 Mar; 270(6):1338-48. PubMed ID: 12631292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A SUMO-regulated activation function controls synergy of c-Myb through a repressor-activator switch leading to differential p300 recruitment.
    Molvaersmyr AK; Saether T; Gilfillan S; Lorenzo PI; Kvaløy H; Matre V; Gabrielsen OS
    Nucleic Acids Res; 2010 Aug; 38(15):4970-84. PubMed ID: 20385574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A non-covalent interaction between small ubiquitin-like modifier-1 and Zac1 regulates Zac1 cellular functions.
    Liu ST; Chang YL; Wang WM; Chung MH; Lin WS; Chou WY; Huang SM
    Int J Biochem Cell Biol; 2012 Mar; 44(3):547-55. PubMed ID: 22227369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stress-induced phosphorylation of Thr486 in c-Myb by p38 mitogen-activated protein kinases attenuates conjugation of SUMO-2/3.
    Bies J; Sramko M; Wolff L
    J Biol Chem; 2013 Dec; 288(52):36983-93. PubMed ID: 24257756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A synergy control motif within the attenuator domain of CCAAT/enhancer-binding protein alpha inhibits transcriptional synergy through its PIASy-enhanced modification by SUMO-1 or SUMO-3.
    Subramanian L; Benson MD; Iñiguez-Lluhí JA
    J Biol Chem; 2003 Mar; 278(11):9134-41. PubMed ID: 12511558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small ubiquitin-related modifier-1 (SUMO-1) modification of the glucocorticoid receptor.
    Tian S; Poukka H; Palvimo JJ; Jänne OA
    Biochem J; 2002 Nov; 367(Pt 3):907-11. PubMed ID: 12144530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The DNA topoisomerase I binding protein topors as a novel cellular target for SUMO-1 modification: characterization of domains necessary for subcellular localization and sumolation.
    Weger S; Hammer E; Engstler M
    Exp Cell Res; 2003 Oct; 290(1):13-27. PubMed ID: 14516784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcription factor AP-2 interacts with the SUMO-conjugating enzyme UBC9 and is sumolated in vivo.
    Eloranta JJ; Hurst HC
    J Biol Chem; 2002 Aug; 277(34):30798-804. PubMed ID: 12072434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-translational modification of POU domain transcription factor Oct-4 by SUMO-1.
    Zhang Z; Liao B; Xu M; Jin Y
    FASEB J; 2007 Oct; 21(12):3042-51. PubMed ID: 17496161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Kruppel zinc finger of ZNF 146 interacts with the SUMO-1 conjugating enzyme UBC9 and is sumoylated in vivo.
    Antoine K; Prosperi MT; Ferbus D; Boule C; Goubin G
    Mol Cell Biochem; 2005 Mar; 271(1-2):215-23. PubMed ID: 15881673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post-translational modification of Rta of Epstein-Barr virus by SUMO-1.
    Chang LK; Lee YH; Cheng TS; Hong YR; Lu PJ; Wang JJ; Wang WH; Kuo CW; Li SS; Liu ST
    J Biol Chem; 2004 Sep; 279(37):38803-12. PubMed ID: 15229220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Viral oncoproteins E1A and E7 and cellular LxCxE proteins repress SUMO modification of the retinoblastoma tumor suppressor.
    Ledl A; Schmidt D; Müller S
    Oncogene; 2005 May; 24(23):3810-8. PubMed ID: 15806172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. c-Jun and p53 activity is modulated by SUMO-1 modification.
    Muller S; Berger M; Lehembre F; Seeler JS; Haupt Y; Dejean A
    J Biol Chem; 2000 May; 275(18):13321-9. PubMed ID: 10788439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SUMO modification regulates MafB-driven macrophage differentiation by enabling Myb-dependent transcriptional repression.
    Tillmanns S; Otto C; Jaffray E; Du Roure C; Bakri Y; Vanhille L; Sarrazin S; Hay RT; Sieweke MH
    Mol Cell Biol; 2007 Aug; 27(15):5554-64. PubMed ID: 17548468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro modification of human centromere protein CENP-C fragments by small ubiquitin-like modifier (SUMO) protein: definitive identification of the modification sites by tandem mass spectrometry analysis of the isopeptides.
    Chung TL; Hsiao HH; Yeh YY; Shia HL; Chen YL; Liang PH; Wang AH; Khoo KH; Shoei-Lung Li S
    J Biol Chem; 2004 Sep; 279(38):39653-62. PubMed ID: 15272016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of the Ets-1 transcription factor by sumoylation and ubiquitinylation.
    Ji Z; Degerny C; Vintonenko N; Deheuninck J; Foveau B; Leroy C; Coll J; Tulasne D; Baert JL; Fafeur V
    Oncogene; 2007 Jan; 26(3):395-406. PubMed ID: 16862185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.